Obesity and obstructive sleep apnoea: Mechanisms for increased collapsibility of the passive pharyngeal airway

Department of Anesthesiology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Respirology (Impact Factor: 3.5). 01/2012; 17(1):32-42. DOI: 10.1111/j.1440-1843.2011.02093.x
Source: PubMed

ABSTRACT Epidemiological evidence suggests there are significant links between obesity and obstructive sleep apnoea (OSA), with a particular emphasis on the importance of fat distribution in the development of OSA. In patients with OSA, the structure of the pharyngeal airway collapses. A collapsible tube within a rigid box collapses either due to decreased intraluminal pressure or increased external tissue pressure (i.e. reduction in transmural pressure), or due to reduction in the longitudinal tension of the tube. Accordingly, obesity should structurally increase the collapsibility of the pharyngeal airway due to excessive fat deposition at two distinct locations. In the pharyngeal airway region, excessive soft tissue for a given maxillomandibular enclosure size (upper airway anatomical imbalance) can increase tissue pressure surrounding the pharyngeal airway, thereby narrowing the airway. Even mild obesity may cause anatomical imbalance in individuals with a small maxilla and mandible. Lung volume reduction due to excessive central fat deposition may decrease longitudinal tracheal traction forces and pharyngeal wall tension, changing the 'tube law' in the pharyngeal airway (lung volume dependence of the upper airway). The lung volume dependence of pharyngeal airway patency appears to contribute more significantly to the development of OSA in morbidly obese, apnoeic patients. Neurostructural interactions required for stable breathing may be influenced by obesity-related hormones and cytokines. Accumulating evidence strongly supports these speculations, but further intensive research is needed.

1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Before the introduction of the opioids hypnosis, immobility and hemodynamic stability were achieved with deep inhalation agents. These agents induced strong hemodynamic suppression. Therefore the introduction of balanced anaesthesia was a gift. Opioids induced hemodynamic stability by suppressing the sympathetic system. Opioids are the strongest analgesics and there-fore analgesia became an essential part of balanced anaesthesia next to hypnosis and immobility. Is it time today to enhance this vision? At least Paul Janssens, founder of Janssens Pharmaceuticals, who invented all synthetic opioids, warned 20 years ago that the medical use of their formulated remifentanyl can cause addiction, immuno-suppression and other long-term effects that were not obvious at that time. Nevertheless all anaesthesiologists got attracted to these very strong opiates by its seemingly very short activity. Do we need to avoid the opioids peroperative? Most common side effects of opioids are well-known like respiratory depression, pruritus, nausea and vomiting, ileus, constipation, urinary retention, tolerance by desensitisation, reduced cardiac output, dizziness, somnolence and a short central muscle stiffness. A less known side effect is pharyngeal muscle weakness giving obstructive breathing and should be avoided in obese patients [1-3]. A recent guideline of the ASA recommends avoidance or minimizing of perioperative use of respiratory depressants in patients with obstructive sleep apnea [4]. Several reasons are added every year to reduce or avoid the use of synthetic opioids. Enhanced recovery after surgery advocates the strong reduction of opioids postoperative to improve the healing. If no opioids are used during surgery, less opioids are needed to achieve a pain free recovery, as addiction did not destroy yet our mu receptor system. The immunologic defensive cells like monocytes have the highest concentration in opioid receptors, followed far behind by the gastrointestinal system and the neurologic system explaining the dramatic immunologic suppression when using opioids during anaesthesia. Oncologic patients have a better survival when no opioids are used during surgery and brain dysfunction is certainly less in neonates [5, 6]. POCD seems to be also lower and patients have a more natural sleep form the first postoperative day. Opioid induced hyperalgesia and chronic pain syndromes are more frequent when high doses of opioids are used peroperative [7].
    JEPU 2014 Paris; 03/2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Abstract Background: Obstructive sleep apnoea (OSA) is often overlooked in the context of schizophrenia because its hallmark, daytime sleepiness, is so easily attributable to antipsychotic drugs. This is a special problem for women. Aims: To underscore the importance of diagnosing and treating OSA in women with schizophrenia. Methods: A review of the recent literature (search terms: Obstructive Sleep Apnoea; Schizophrenia; Women (or Gender); Obesity; Antipsychotics; Continuous Positive Airway Pressure (CPAP)) as it applies to a composite case vignette taken from the files of a specialty clinic that treats women with psychosis. Results: The rate of OSA in women who are both obese and postmenopausal is very similar to that of men. Family history, smoking, and the use of tobacco, alcohol and of antipsychotic medication increase the risk. Despite reluctance, patients with schizophrenia generally agree to undergo sleep studies. Compliance with CPAP is difficult, but can be aided by the physician and is, on the whole, relatively high in women. CPAP improves sleep parameters and may also improve cardiometabolic and cognitive indices, although this still needs to be more fully researched. Conclusion: Schizophrenia and untreated OSA are both associated with high mortality rates in women as well as men.
    Journal of Mental Health 01/2014; 23(4):191-196. DOI:10.3109/09638237.2013.869572 · 1.01 Impact Factor
  • Chest 10/2010; 138(4 MeetingAbstracts):703A-703A. DOI:10.1378/chest.10859 · 7.13 Impact Factor